CPH 0.00% 0.9¢ creso pharma limited

Ann: Creso Reports Strong Financial Performance in FY22, page-16

  1. 1,925 Posts.
    lightbulb Created with Sketch. 581
    I'm not interested in the history of the poor management who incidentally are no longer at CPH. I'm only interested in current management team and Board of Directors who appear to be doing a few good things in case you haven't noticed...Sierra Sage, Health House International, Mernova etc.

    My entry price is around 3c so I am annoyed looking at 1.2c, 1.3c 1.4c.

    I believe we will see better days soon once this quarter is finalized and we move into the second half of 2023. Be patient and rewards will flow in my opinion.
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.